Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway | |
Lu, Yao; Jiang, Zhou; Dai, Haijiang; Miao, Rujia; Shu, Jingxian; Gu, Haotian; Liu, Xing; Huang, Zhijun; Yang, Guoping; Chen, Alex F. | |
刊名 | Hepatology
![]() |
2018 | |
卷号 | 67期号:4页码:1303-1319 |
ISSN号 | 1527-3350 |
DOI | 10.1002/hep.29633 |
URL标识 | 查看原文 |
WOS记录号 | WOS:000428332600016 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3338030 |
专题 | 中南大学 |
作者单位 | 1.[Chen, Alex F. 2.Huang, Zhijun 3.Liu, Xing 4.Yuan, Hong 5.Lu, Yao 6.Dai, Haijiang 7.Yang, Guoping 8.Shu, Jingxian] Cent S Univ, Xiangya Hosp 3, Ctr Clin Pharmacol, Changsha, Hunan, Peoples R China. |
推荐引用方式 GB/T 7714 | Lu, Yao,Jiang, Zhou,Dai, Haijiang,et al. Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway[J]. Hepatology,2018,67(4):1303-1319. |
APA | Lu, Yao.,Jiang, Zhou.,Dai, Haijiang.,Miao, Rujia.,Shu, Jingxian.,...&Cai, Jingjing*.(2018).Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway.Hepatology,67(4),1303-1319. |
MLA | Lu, Yao,et al."Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway".Hepatology 67.4(2018):1303-1319. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论